Oral Cyanocobalamin is Effective in the Treatment of Vitamin B12 Deficiency in Crohn’s Disease
Fernando Gomollón 1,2,3,4,*,†, Carla J. Gargallo 1,2,†, Jose Fernando Muñoz 5, Raquel Vicente 6, Alberto Lue 1,2
, Alberto Mir 7, Marta García-Alvarado 8, Marta Gracia 6 and Santiago García-López 6
, Alberto Mir 7, Marta García-Alvarado 8, Marta Gracia 6 and Santiago García-López 6
1
Hospital Clínico Universitario “Lozano Blesa”, Avenue San Juan Bosco, 15, Zaragoza 50009, Aragón, Spain
2
Aragón Health Research Institute (IIS Aragón), Zaragoza 50009, Aragón, Spain
3
University of Zaragoza, Zaragoza 50009, Aragón, Spain
4
Centro de Investigación Biomédica en Red, Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid 28029, Spain
5
Hospital Universitario de Salamanca, Salamanca 37007, Castilla y León, Spain
6
Hospital Universitario Miguel Servet, Zaragoza 50009, Aragón, Spain
7
Hospital Ernest Lluch Martin, Calatayud, Zaragoza 50299, Aragón, Spain
8
Hospital Virgen de la Concha, Zamora 49022, Castilla y León, Spain
*
Author to whom correspondence should be addressed.
†
Fernando Gomollón and Carla J. Gargallo is dual first authorship due to equal contribution.
Nutrients 2017, 9(3), 308; https://doi.org/10.3390/nu9030308
Received: 18 January 2017 / Revised: 23 February 2017 / Accepted: 13 March 2017 / Published: 20 March 2017
(This article belongs to the Special Issue Nutrition and Diet in IBD)
Abstract
Cobalamin deficiency is common in patients with Crohn’s disease (CD). Intramuscular cobalamin continues to be the standard therapy for the deficiency and maintenance treatment in these patients, although oral route has been demonstrated to be effective in other pathologies with impaired absorption. Our aims were to evaluate the efficacy of oral therapy in the treatment of cobalamin deficiency and in long-term maintenance in patients with Crohn’s disease. We performed a multicenter retrospective cohort study that included 94 patients with Crohn’s disease and cobalamin deficiency. Seventy-six patients had B12 deficiency and 94.7% of them normalized their cobalamin levels with oral treatment. The most used dose was 1 mg/day, but there were no significant differences in treatment effectiveness depending on the dose used (≥1 mg/24 h vs. <1 mg/24 h). Eighty-two patients had previous documented B12 deficiency and were treated with oral B12 to maintain their correct cobalamin levels. After a mean follow-up of 3 years, the oral route was effective as maintenance treatment in 81.7% of patients. A lack of treatment adherence was admitted by 46.6% of patients in who the oral route failed. In conclusion, our study shows that oral cyanocobalamin provides effective acute and maintenance treatment for vitamin B12 deficiency caused by CD with or without ileum resection. View Full-TextKeywords:
vitamin B12 deficiency; cobalamin deficiency; Crohn’s disease; ileal resection; oral treatment; acute treatment; maintenance treatment
▼
Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
Gomollón, F.; Gargallo, C.J.; Muñoz, J.F.; Vicente, R.; Lue, A.; Mir, A.; García-Alvarado, M.; Gracia, M.; García-López, S. Oral Cyanocobalamin is Effective in the Treatment of Vitamin B12 Deficiency in Crohn’s Disease. Nutrients 2017, 9, 308.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
Related Articles
Article Metrics
Comments
[Return to top]
Nutrients
EISSN 2072-6643
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert